Associations Between Gut Microbiota and Immune Profiles in Community‐Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum Tingting Xia, Hongmei Wu, Tianyi Cui, Wenzhi Yang, Min Zhang, Yuhong Huang, Shengyuan Zhou, Yongsheng Wu, Donglan Yan, Fan Jia, Lin Zhang, Zhi Cui, Jiayao An, Xinqin Zhong, Bin Lv, Xin Zhao, Kaijun Niu, Xiumei Gao Abstract Aging is often associated with intestinal microbiota imbalance and immune system degeneration. The dysregulation and crosstalk of these two factors markedly elevate the elderly's susceptibility to infections and age‐related diseases. Polygonatum odoratum, a traditional Chinese medicinal herb, is widely used in geriatric care for its lung‐moistening and nourishing effects. However, its potential regulatory roles on the microbiota and immunity in the aging context remain unreported. A total of 140 independently living elderly individuals aged 60 and above were recruited for this study. The randomized, double‐blinded study including YZG (P. odoratum) and placebo groups was performed for 90 days' intervention. Peripheral blood immune cell subsets were analyzed by flow cytometry, and microbial diversity in fecal samples was assessed by 16S rRNA sequencing. Baseline correlation analysis revealed that alterations in gut microbiota were predominantly associated with T cell subsets. Specifically, Akkermansia showed a significant negative correlation with age‐related memory T cells, including CD4+ and CD8+ TEMRA. Additionally, Klebsiella exhibited a significant positive correlation with partial subsets of CD4+ TEMRA. After 90‐day YZG intervention, the percentage of TEMRA and CD28− CD57+ TEMRA cells were reduced in elderly subjects. The relative abundance of Prevotella 9 and Akkermansia were increased, and the abundance of Klebsiella in the gut microbiota were significantly decreased. Correlation analysis linked YZG‐induced gut microbiota changes to improved immunity and fewer respiratory infections. This study demonstrates significant correlations that exist between immunosenescence in T‐cell compartments and gut microbial composition, suggesting a potential interplay between microbial health and immune aging. Trial Registration: UMIN Clinical Trials Registry identifier: UMIN000052572 Gut Microbiota‐Immune Associations in Community‐Dwelling Older Adults: Role of Polygonatum odoratum.[ACEL-25-e70724-g002.webp] Introduction The aging process is accompanied by an age‐dependent decline in immune system function, known as immunosenescence, the most prominent feature of which is the aging of T cells (Wang et al. ). With aging, the number of naïve T cells decreases, whereas memory T cells increase. Notably, the accumulation of terminally differentiated memory T cells re‐expressing CD45RA (TEMRA) is particularly prominent and exhibits typical features of cellular senescence, such as telomere shortening, an enhanced senescence‐associated secretory phenotype, and cell cycle arrest (Lance et al. ). They not only occupy the immunological niche but also exacerbate the chronic inflammatory environment and impair the clearance of pathogens. Particularly, promoting the clearance and accumulation of terminally differentiated memory T cells CD57+ CD28− subset represents an important strategy for delaying the onset and progression of age‐related diseases (Salumets et al. ). The aging process is often accompanied by an imbalance in intestinal microecological homeostasis, primarily characterized by reduced microbial diversity, excessive colonization by harmful bacteria, and decreased abundance of beneficial bacteria. These alterations can compromise intestinal barrier integrity, impair the body's immune function, and subsequently drive the onset and progression of chronic inflammation, neuroinflammation, metabolic syndrome, gut‐brain axis dysregulation, and neurodegenerative diseases (Gu et al. ; Liang et al. ). Comparative studies indicate that, relative to elderly high‐level orienteering athletes who experience mild gastrointestinal symptoms and report higher life satisfaction, the general elderly population exhibits a significantly lower abundance of beneficial bacteria such as Akkermansia muciniphila and Faecalibacterium prausnitzii in their intestines (Schoultz et al. ). Reconstructing and maintaining intestinal microbiota homeostasis is a necessary strategy for promoting healthy aging in the elderly population. Exploring the link between the gut microbiota and the immune system has emerged as a critical therapeutic target in aging and related disease management (Ding et al. ). Several clinical studies demonstrated that probiotic intervention modulated systemic immune markers in patients with syndrome, while another cohort study revealed that specific gut microbial signatures were closely correlated with immune profiles in elderly populations (Zhu et al. ). The community‐dwelling older adults—a population in which such attention is often lacking before the onset of clinical disease (Colica and Vecchio ), often indulge in immune‐boosting herbal remedies, hailed as panaceas, yet blindly consume them without grasping their true effects—a testament to the gap between tradition and scientific understanding. Polygonati Odorati Rhizoma (Polygonatum odoratum, Yuzhu in Chinese) is a representative of the bodybuilding and yin‐nourishing herbs. P. odoratum is clinically used for elderly people in the prevention and treatment of respiratory tract infection and the related symptoms (Nan et al. ). It shows good pharmacological activities including anti‐inflammatory, antioxidant, hypoglycemic and lipid‐lowering, immune regulation, anti‐aging, regulating gut microbiota, and reducing obesity (Zhao et al. ). Its active components mainly include polysaccharides, saponins, flavonoids, anthraquinones, lectins, and other compounds (Zhao et al. ). However, the underlying boosting mechanism of P. odoratum on immunosenescence and gut microbiot in the elderly population is still unclear. In this study, we first investigated the associations between the gut microbiota and immune cell subsets in a primary elderly population composed of community‐dwelling older adults. Subsequently, through an intervention trial, the effects of P. odoratum on reshaping host immune homeostasis as indicated by peripheral blood immune cell subsets and modulating the fecal microbial composition were systematically evaluated. We aim to provide a scientific foundation for elucidating the association between gut microbiota and immunity in community‐dwelling older adults, and for evaluating the interventional effects of commonly used supplements, such as P. odoratum. Methods Study Design We recruit the elderly people in community of Tianjin and designed a double‐blind randomized controlled trial, which has been registered with the UMIN Clinical Trials Registry (Identifier: UMIN000052572). Ethical approval was given by the Research Ethics Committee of the Second Affiliated Hospital of Tianjin University of Chinese Medicine (Project No. EC.AT/03.19‐01/10.0) and was conducted in accordance with the guidelines set out in the Declaration of Helsinki. All the participants gave written informed consent. Study Recruitment and Participants A total of 186 participants were recruited by the physician from three communities between November 2023 and March 2024 in Tianjin, China, with the selection process described in Figure . Inclusion criteria were as follows: (1) age ≥ 60 years; (2) no communication and intellectual disabilities, able to live independently; (3) long term residence in Tianjin; (4) agreement to study follow‐up. Exclusion criteria include: (1) age < 60 years; (2) patients with severe depression, severe dementia, and visual or hearing impairment; (3) severe cardiovascular and cerebrovascular diseases (coronary heart disease, stroke, and myocardial infarction, etc.), tumors, liver and kidney diseases, etc.; (4) have a history of asthma, allergies, or allergies; (5) cannot complete the follow‐up. Randomization and Masking The elderly people in the study population were randomized into intervention group and control group in a 1:1 ratio. The double‐blind experiment was used, and neither the elderly participants nor the researchers could know the specifics of the group until the end of the clinical trial. The follow‐up process is depicted in Figures and . Intervention Both Yuzhu Gao (YZG) for YZG group and placebo (Con) for control group used in the study were provided by Jiuzhitang Co. Ltd. (Lot No. 041A‐2203001‐11, China). YZG is a 100% aqueous extract of Polygonatum odoratum (Mill.) Druce, which is prepared by extracting the raw material with water three times, followed by concentration, standing, filtration, and final packaging. YZG and placebo are the same texture and adopt the same packaging and specifications. The polysaccharide content as quality control of YZG was extracted and detected with multi‐level fingerprinting (Liu et al. ). An ultra‐high‐performance liquid chromatography‐Q exactive hybrid quadrupole orbitrap high‐resolution accurate mass spectrometer (Vion IMS‐QTOF) analysis was performed for the non‐polysaccharide components dection (Figure and Table ). Assessments of Clinical Outcomes Peripheral blood samples and fecal samples were collected at day 0 and the end of the intervention (day 90). Immune cell parameters in peripheral blood were examined by flow cytometry (BD FACSAria III flow cytometry, BD Biosciences) and antibodies were purchased from Biolegend (antibody labeling: Table and circle gate strategy: Figure ). Fecal gut microbiome composition was measured by V3‐V4 regions of 16S rRNA sequencing (LC‐Bio Technology Co. Ltd., Hangzhou, China). Blood immune markers and gut microbiome were the primary outcomes of this study, while respiratory infection incidence and other clinical symptom ratings were secondary outcomes. There was no adverse event throughout the intervention period. Detailed methodological information and other relevant variables are described in the Materials and Methods section in the . Statistical Analysis Statistical analysis was performed using GraphPad Prism 8.0.1, with qualitative data expressed as percentages (%) and analyzed by Chi‐square test, while quantitative data were presented as Mean ± SD (analyzed by ANOVA/t‐test for normally distributed data) or median and IQR (analyzed by Kruskal–Wallis/Mann–Whitney test for non‐normally distributed data), using two‐sided tests with p < 0.05 considered significant. 16S rRNA data were analyzed using R‐4.4.2: alpha diversity (violin plots, Wilcoxon test), beta diversity (PCoA, PERMANOVA), species abundance (Kruskal–Wallis/ANCOM‐BC), and microbiota‐immunity correlations (Spearman). The detailed information can be seen in Materials and Methods (). Results General Information of Participants The baseline characteristics of the two groups (n = 70) were roughly the same between our YZG and placebo groups (Table ). Individuals who completed the trial (n = 65) were included in the endpoint analysis. In addition, ITT analysis was performed for all 140 individuals by replacing the missing data with the last observed value. Blood Routine, Liver and Kidney Function and Lipid Profile The results of blood tests are shown in Table . After intervention in the YZG group, there was a significant increase in glycosylated hemoglobin, serum albumin, high‐density lipoprotein cholesterol, and serum total protein, while the mean corpuscular hemoglobin concentration, mean corpuscular hemoglobin, and uric acid levels decreased significantly. No significant differences were observed in the remaining blood test parameters. Relationships Between Blood Immune Cell Subsets and Gut Microbiota Profiles and in the Elderly At baseline, correlation analysis was performed between gut microbiota and immune cell subsets in a cohort of 125 elderly individuals. The results revealed that alterations in gut microbiota were predominantly associated with T cell subsets. Akkermansia was significantly negatively correlated with the CD8+ terminally differentiated effector memory T cell (TEMRA) CD57− CD28− (r = −0.244, p = 0.006), CD8+ central memory T cells (TCM) (r = −0.205, p = 0.022), and double‐negative B cells (DN B) (r = −0.244, p = 0.044), while it was significantly positively correlated with the CD4+ TEMRA CD57− CD28+ (r = 0.197, p = 0.027) and naïve CD4+ T cells. Bifidobacterium showed a significant positive correlation with DN B cells (r = 0.205, p = 0.022). Christensenellaceae_R‐7_group was significantly negatively correlated with the CD8+ TEMRA CD57− CD28− (r = −0.197, p = 0.028). Coprococcus was significantly negatively correlated with CD8+ TEMRA (r = −0.227, p = 0.011), the CD8+ TEMRA CD57− CD28− (r = −0.223, p = 0.012), and the CD8+ TEMRA CD57+ CD28− subset (r = −0.187, p = 0.036). The Eubacterium eligens group demonstrated significant negative correlations with CD8+ TEMRA CD57− CD28+ (r = −0.370, p = 2.142), CD8+ TEMRA CD57+ CD28+ (r = −0.238, p = 0.008), CD8+ TEMRA (r = −0.233, p = 0.009), and CD4+ TEMRA CD57− CD28+ (r = −0.196, p = 0.028). Conversely, it showed significant positive correlations with NK CD16− (r = 0.263, p = 0.003), CD8+ TEM CD57− CD28− (r = 0.234, p = 0.009), CD8+ TEM CD57+ CD28− (r = 0.218, p = 0.015), and CD8+ TEM CD57+ CD28+ (r = 0.186, p = 0.038). Parabacteroides was significantly negatively correlated with long‐lived memory B cells (Lgm B) (r = −0.189, p = 0.035). Phascolarctobacterium was significantly negatively correlated with the CD8+ effector memory T cell (TEM) CD57− CD28− (r = −0.193, p = 0.030). Streptococcus was significantly negatively correlated with the CD8+ TEMRA CD57− CD28− (r = −0.198, p = 0.027). Subdoligranulum was significantly negatively correlated with the CD8+ TEMRA CD57− CD28− (r = −0.219, p = 0.014) and CD8+ TEMRA (r = −0.181, p = 0.044). Sutterella was significantly negatively correlated with CD8+ TEMRA (r = −0.224, p = 0.012) and the CD8+ TEMRA CD57+ CD28− (r = −0.184, p = 0.040). A significant negative correlation was observed between Roseburia and CD8+ TEMRA CD57−CD28+ cells (r = −0.227, p = 0.011), while a significant positive correlation was identified with CD8+ TEM CD57+ CD28− (r = 0.183, p = 0.042). Sutterella exhibited significant negative correlations with CD8+ TEMRA (r = −0.224, p = 0.012) and CD8+ TEMRA CD57+ CD28− (r = −0.184, p = 0.040). Positive correlations were found between Sutterella and CD8+ TEM CD57+ CD28+ (r = 0.234, p = 0.009), CD4+ TCM (r = 0.231, p = 0.009), CD8+ TEM CD57− CD28− (r = −0.209, p = 0.019), and CD8+ TEM cells (r = 0.204, p = 0.023). Klebsiella was positively correlated with CD4+ TEMRA CD57+ CD28+ (r = 0.257, p = 0.004), IgM+ B cells (r = 0.224, p = 0.012), CD8+ TEMRA CD57+ CD28+ (r = 0.209, p = 0.019), CD4+ TEMRA CD57− CD28+ (r = 0.209, p = 0.020), CD4+ TEMRA CD57−CD28− (r = 0.120, p = 0.025), and CD4+ TEMRA cells (r = 0.188, p = 0.036). Lachnoclostridium showed a positive correlation with naïve B cells (r = 0.177, p = 0.048). Parasutterella was positively correlated with CD4+ TEM CD57− CD28− (r = 0.304, p = 0.001), CD4+ TEM CD57+ CD28− (r = 0.283, p = 0.001), and CD4+ TEM cells (r = 0.201, p = 0.025). Prevotella 9 demonstrated positive correlations with CD4+ TEMRA CD57− CD28− (r = 0.201, p = 0.024), CD4+ TEMRA CD57+ CD28− (r = 0.188, p = 0.034), and CD8+ TEM CD57− CD28+ cells (r = 0.182, p = 0.042). Ruminococcus was positively correlated with CD8+ TEM CD57+ CD28+ (r = 0.264, p = 0.003) and CD8+ TEM CD57+ CD28− (r = 0.177, p = 0.048). Specifically, Akkermansia demonstrated a significant negative correlation with partial subsets of CD8+ TEMRA, and positive correlation with naïve CD4+ T. Additionally, Klebsiella exhibited a significant positive correlation with partial subsets of CD4+ TEMRA and CD8+ TEMRA (Figure ). Yuzhu Gao Alters Blood Immune Cell Subsets in the Elderly Flow cytometry was performed in the peripheral blood of the placebo group (Control) and the intervention group (YZG) before and after the intervention. The flow gate strategy and the situation of T cells between the Day 90 and baseline of the YZG and control groups (Figure ). After 90 days of intervention, there were no significant differences in the percentage of CD8+ T cells and CD4+ T cells and the ratio of CD4+ T/CD8+ T between the YZG group and the control group. After 90 days of intervention, significant decreases in CD8+ TCM, CD4+ TCM, and CD8+ TEM were observed in the control group, while significant increases were noted in CD8+ TEMRA, CD4+ TEMRA, CD28− CD57+ CD8+ TEMRA, and CD28− CD57+ CD4+ TEMRA (p < 0.01). Following intervention with YZG, a significant increase in CD8+ TCM was observed, with no significant changes detected in the remaining subsets (p < 0.01) (Figures and ). We compared the difference between the end point minus baseline in the YZG group and the end point minus baseline in the control group. The between‐group analysis in the YZG group showed a significantly lower increase in the percentage of Naïve CD8+ T cells and CD8+ TEMRA cells. The percentage of CD8+ TCM cells was significantly up‐regulated in the YZG group and down‐regulated in the control group after 90 days intervention. The percentage of CD8+ TEM cells was significantly down‐regulated in the control group, and no significant change was observed in the YZG group after 90 days intervention (Figure ). A similar trend was also observed in the CD4+ T cell subset (Figure ). In addition, the change in endpoints minus baseline differences between the two groups of these cell subsets was consistent with the change in the percentage of CD8+ T cells or CD4+ T cells in the CD45+ cell population (Figure ). The CD28− CD57+ TEMRA cells were significantly up‐regulated in the control group and no significant change in the YZG group after 90 days intervention (Figure ). The between‐group analysis in the YZG group showed a significantly lower increase in the percentage of CD28− CD57+ TEMRA, compared with that in the control group. The trend of its variation remains consistent across different cell population proportions (Figure ). Comparing the data of YZG group and control group, no significant results were observed in the percentage of DN (double negative) B cells (CD45+ CD3− CD19+ IgD− CD27−) and NK cells (CD45+ CD3− CD56+) (Figure ). Yuzhu Gao Modulates Gut Microbiota Composition in the Elderly In the alpha diversity analysis based on the obtained ASV feature sequences and ASV abundance tables, the Chao1 and observed species were significantly higher at Day 90 of the YZG group compared to that of the baseline, whereas there was no significant difference between the baseline and Day 90 of the control group (Figure ). The results demonstrated that no statistically significant differences in alpha diversity were observed either at baseline or after adjusting for relevant confounding factors (Table ). The beta diversity among groups was characterized by weighted‐based PCoA analysis. There was no significant difference in the composition of microbial between the YZG and control groups (Figure ). The most relative abundance phylum was Firmicutes (50.2%), followed by Bacteroidota (25.7%), Proteobacteria (10.6%), and Actinobacteriota (10.2%). These four phyla accounted for about 96.9% of the gut microbiota. The composition of the gut microbiome of participants in the YZG and control groups was characterized at both baseline and Day 90 (Figure ). Based on the analysis of species differences at the phylum level, compared to baseline, the relative abundance of Firmicutes increased in the control group on Day 90, while the relative abundance of Verrucomicrobiota decreased significantly and the relative abundance of Bacteroidota decreased. In the YZG group, the abundance of Verrucomicrobiota increased significantly. Evaluating the difference between Day 90 and baseline, the relative abundance of Actinobacteriota decreased more significantly in the control group compared to the YZG group (p < 0.001). According to the analysis of abundance differences at the genus level, compared to baseline, the relative abundance of Faecalibacterium increased significantly in both the YZG and control groups on Day 90. The relative abundance of Prevotella 9 and Akkermansia increased significantly in the YZG group, while there was no significant difference in the control group before and after intervention. The relative abundance of Klebsiella decreased significantly in the YZG group, while there was no significant difference in the control group before and after intervention. Evaluating the difference between Day 90 and baseline, the relative abundance of Prevotella 9 was significantly higher in the YZG group compared to the control group. Based on the species‐level differences analysis (Figure , Table ). We also conducted an analysis before and after intervention in the YZG group, and the key bacteria was figured out by cutting |logFC| ≥ 1.5. The relative abundance of Brevundimonas sp. FXJ8.069, Enterococcus faecium , Morganella morganii, unclassified Hydrogenophaga, unclassified Sphingomonas, Olsenella phocaeensis, Enterococcus sp., Leifsonia sp. DABST80, unclassified Muribaculaceae, and Bacillus sp. NJ‐82 was significantly upregulated. Although the relative abundance of Brevundimonas sp. FXJ8.069, unclassified Hydrogenophaga, Leifsonia sp. DABST80, unclassified Sphingomonas, and Olsenella phocaeensis also increased significantly in the control group after intervention, this upward trend was more pronounced in the YZG group. Following intervention in the YZG group, the relative abundance of Klebsiella pneumoniae , Lactobacillus intestinalis , and Arthrobacter sp. NW‐2013‐Rh11 was significantly downregulated (p < 0.01). The intervention predominantly influences microbial composition by altering the relative abundance of species in the certain genera, including Faecalibacterium, Prevotella 9, Akkermansia, Klebsiella, Enterococcus, Clostridiales, Bacteroides, Subdoligranulum, Sutterella, Eubacterium, etc. Yuzhu Gao Altered Immune Status Relates to the Alteration Gut Microbial Genus in the Elderly After the intervention, the correlation between T‐cell subsets and bacterial relative abundance at the genus level was analyzed using Spearman's correlation analysis, with the results presented in Figure . Prevotella 9 was significantly negatively correlated with CD4+ T and CD4+ TEM (r = −0.143, p = 0.030); Faecalibacterium was significantly negatively correlated with CD4+ TEM (r = −0.155, p = 0.019); Akkermansia was significantly negatively correlated with CD8+ TEM (r = −0.133, p = 0.044) and positively correlated with naïve CD4+ T (r = 0.143, p = 0.030). During the administration intervention period, the incidence of respiratory tract infections and the total symptom score were assessed through questionnaire follow‐up (Patel et al. ). Feedback was received from a total of 116 participants, with 56 in the intervention group (YZG) and 60 in the placebo group (Control). Compared with the control group, the incidence of respiratory tract infection in the YZG group was significantly decreased (Table ). We also analyzed the relationship between the respiratory tract infection (RTI) and immune and gut microbial index altered by Yuzhu Gao (YZG). The results demonstrated that the key bacterial genera (e.g., Faecalibacterium, Prevotella 9, Akkermansia, Klebsiella, Subdoligranulum, Sutterella) altered by YZG, correlating with enhanced immune function (particularly T‐cell profiles), showed a significantly impact of respiratory infections during the intervention period (Figures ). Discussion A dynamic bidirectional regulatory network exists between the gut microbiota and the host immune system (Ghosh and Sinha ; Wang et al. ). In this cohort study focusing on an elderly population, a significant association between gut microbiota composition and host immune cell subsets was investigated. The results showed that the relative abundances of key bacterial taxa, including Bifidobacterium, Ruminococcaceae, Akkermansia, and Klebsiella, exhibited specific correlations with various immune cell genealogies. Among these, Akkermansia, Eubacterium and Parabacteroides were significantly negatively correlated with TEMRA cells. There is a significant positive correlation between CD4+ TEMRA CD57− CD28+ and CD4+ TEMRA cells and Klebsiella. The high abundance of Akkermansia is closely linked to positive health outcomes in various aging‐related diseases, and it is notably higher in the longevity group (Panzetta and Valdivia ). Additionally, Prevotella is associated with lower levels of depression and anxiety in patients with IBD and healthy individuals (Yuan et al. ). Members of the Klebsiella genus have rapidly evolved, resulting in multidrug‐resistant and highly virulent organisms closely related to infections in immunocompromised hosts, such as community‐acquired infections, posing a serious threat to global clinical and public health (Dong et al. ). Akkermansia muciniphila shows a significant positive correlation with the clinical response rate to PD‐1 immune checkpoint blockade therapy. The underlying mechanism may be closely related to the directed recruitment of CCR9+ CXCR3+ CD4+ T lymphocytes to the tumor microenvironment and the upregulation of interleukin‐12 (IL‐12) secretion levels (Routy et al. ). Another mechanistic study demonstrated that in Tfamfl/flCD4Cre conditional deletion mice, the abundance of beneficial commensal bacteria represented by Lactobacillus and Ruminococcaceae was significantly reduced (Gómez de Las Heras et al. ). This finding further untangles, from a genetic perspective, the reverse regulatory role of immune cell functional status on gut microbiota structure, corroborating the complex and precise interaction between the gut microbiota and the immune system. In summary, the dynamic interactive dialog between the gut microbiota and the host immune system holds significant biological importance in maintaining host‐microbiota symbiotic homeostasis and regulating the process of immunosenescence. This provides a crucial theoretical basis for understanding aging‐related immune function decline and for developing gut microecological intervention strategies. There is a lack of clinical evidence regarding the impact of P. odoratum on immune parameters and gut microbiota. Our study demonstrates that YZG not only modulates gut microbial diversity by increasing the abundance of Akkermansia and Prevotella 9 while reducing the abundance of Klebsiella and Ruminococcus gnavus groups, but also significantly decreases the percentage of CD4+ TEMRA, CD8+ TEMRA, and the more senescent CD28− CD57+ CD4+ TEMRA and CD28− CD57+ CD8+ TEMRA cells, thereby effectively enhancing the clearance efficiency of senescent immune cells in the peripheral blood of the elderly. Concurrently, this study observed that YZG significantly reduces the risk of respiratory tract infections in the elderly population. Comparative analysis of gut microbiota structure and T‐cell phenotypes between elderly subjects with and without respiratory tract infections further confirmed the synergistic regulatory role of gut microbiota and T‐cell phenotypes in delaying disease progression in the elderly. Respiratory tract infection represents a prevalent health concern in the elderly population, especially during winter, and is closely linked to age‐associated alterations in immune indicators (Sjögren et al. ). As a traditional Chinese medicinal herb, P. odoratum is widely used in the YZG of respiratory tract infections due to its properties of nourishing yin and moistening the lungs. We collected information on the incidence rate of colds to observe the effect of improvement and analyzed the relationship among infection, immune cells, and gut microbiota. The study found that the trend of changes in immune cells was consistent whether infection occurred (Figure ). Furthermore, previous clinical studies (Chen et al. ) have primarily focused on age‐related changes in T cells among the elderly, while research and exploration into traditional Chinese medicine or botanical drugs targeting TEMRA cells to delay immunosenescence remain insufficient. The potential mechanism underlying the pharmacological effects of YZG may involve modulating gut microbiota structure, promoting the proliferation of beneficial bacteria, and inducing the production of various beneficial metabolites, thereby mediating immunoregulation (Ghosh and Sinha ). Simultaneously, it may also be closely associated with improving T‐cell immune defense function and inhibiting the colonization of harmful gut bacteria. Previous studies have confirmed that Akkermansia muciniphila is significantly enriched in the gut microbiota of long‐lived elderly individuals. This bacterium can synthesize and elevate beneficial metabolites such as short‐chain fatty acids, which regulate T‐cell differentiation by inhibiting the release of pro‐inflammatory cytokines and mitigating chronic inflammatory responses and oxidative stress damage (Alexander et al. ; Shaheen et al. ). Another study indicated that supplementation with Akkermansia muciniphila preparations can promote the infiltration of CAR‐T cells into bone marrow tissue, reverse the imbalance in the CD4/CD8 CAR‐T cell ratio, induce Tc1‐type CD8+ T cell polarization, and promote the release of tryptophan‐derived indole metabolites, ultimately enhancing the body's immune surveillance and control over tumors (Marcos‐Kovandzic et al. ). As core effector cells of the adaptive immune system, the normalization of T‐cell function can effectively mediate pathogen clearance, tissue damage repair, and establish long‐term immune memory against respiratory bacterial infections. Research has confirmed that the B and T lymphocyte attenuator (BTLA) can mediate CD4+ T cell exhaustion by inhibiting T‐cell activation, proliferation, and cytokine secretion, or by inducing CD4+ T cell apoptosis. Intervention with neutralizing anti‐BTLA antibodies significantly reduces the colonization load of Klebsiella pneumoniae and lowers mortality in mouse models of hepatitis B virus‐associated acute‐on‐chronic liver failure (Yu et al. ). In summary, the results of this study fully corroborate the unique pharmacological advantage of YZG as a traditional Chinese medicine for multi‐target and multi‐pathway intervention, suggesting broad application prospects for YZG in the prevention of infectious diseases and the control of chronic non‐communicable diseases in the elderly population. The present study has some strengths and weaknesses. First, this is the first randomized clinical trial that investigated the correlations between immune cell subsets and gut microbiota abundance in the elderly cohort recruited from the Tianjin community, and the effect of P. odoratum supplementation on elderly individuals, especially on respiratory tract infection, T cell subsets and gut microbiota homeostasis. Additionally, individuals had high adherence to treatment considering regular weekly reminders and follow‐up. However, it limits the generalizability of our findings to the Tianjin elderly community population. Several covariates such as blood index, weight, age, and gender was considered in this trial; nevertheless, other confounders such as the presence of comorbid viral infectious diseases such as cytomegalovirus infection in the elderly population which may affect our results remained to be assessed. Furthermore, evaluations of respiratory infection symptoms of participants were based on self‐reported data which might be subject to various biases such as reactivity or selective‐reporting bias. Importantly, no functional immune assays (e.g., anti‐viral T cell responses) were performed in this study. Thus, the observed correlations between YZG treatment, immune cell subsets, and self‐reported cold episodes do not establish causation. Functional studies are needed to confirm anti‐viral immune effects. Finally, While we characterized gut microbial composition at the bacterial level using 16S rRNA sequencing, we did not measure microbial metabolites or structural components (e.g., short‐chain fatty acids, secondary bile acids, tryptophan metabolites, lipopolysaccharide) that could directly influence T‐cell differentiation, activation, or senescence. These functional outputs are critical mediators of host‐microbe communication. In summary, P. odoratum, a food homology and medicinal herb, commonly, can enhance the immune function, and assist in the treatment of various chronic diseases. This clinical study revealed that P. odoratum is suitable for the elderly population daily supplementation, can improve immunity, alleviate aging‐related intestinal dysfunction, and prevent respiratory infections. Ethics Statement Ethical approval was given by the Research Ethics Committee of the Second Affiliated Hospital of Tianjin University of Chinese Medicine (Project No. EC.AT/03.19‐01/10.0) and was conducted in accordance with the guidelines set out in the Declaration of Helsinki. All the participants gave written informed consent. Consent The authors have nothing to report.